U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H20N2O
Molecular Weight 244.3321
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-MEO-MPMI

SMILES

COC1=CC2=C(NC=C2C[C@H]3CCCN3C)C=C1

InChI

InChIKey=MKEGUJPBCIXABO-GFCCVEGCSA-N
InChI=1S/C15H20N2O/c1-17-7-3-4-12(17)8-11-10-16-15-6-5-13(18-2)9-14(11)15/h5-6,9-10,12,16H,3-4,7-8H2,1-2H3/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C15H20N2O
Molecular Weight 244.3321
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:08:23 GMT 2025
Edited
by admin
on Mon Mar 31 23:08:23 GMT 2025
Record UNII
N29TFW7VRV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(R)-3-(N-METHYLPYRROLIDIN-2-YLMETHYL)-5-METHOXYINDOLE
Preferred Name English
5-MEO-MPMI
Common Name English
1H-INDOLE, 5-METHOXY-3-(((2R)-1-METHYL-2-PYRROLIDINYL)METHYL)-
Systematic Name English
5-METHOXY-N-METHYL-(.ALPHA.,N-TRIMETHYLENE)TRYPTAMINE
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-5-MeO-MPMI
Created by admin on Mon Mar 31 23:08:23 GMT 2025 , Edited by admin on Mon Mar 31 23:08:23 GMT 2025
Code System Code Type Description
WIKIPEDIA
5-MEO-MPMI
Created by admin on Mon Mar 31 23:08:23 GMT 2025 , Edited by admin on Mon Mar 31 23:08:23 GMT 2025
PRIMARY 5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992,[1] and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.
CAS
143321-57-7
Created by admin on Mon Mar 31 23:08:23 GMT 2025 , Edited by admin on Mon Mar 31 23:08:23 GMT 2025
PRIMARY
PUBCHEM
9881324
Created by admin on Mon Mar 31 23:08:23 GMT 2025 , Edited by admin on Mon Mar 31 23:08:23 GMT 2025
PRIMARY
FDA UNII
N29TFW7VRV
Created by admin on Mon Mar 31 23:08:23 GMT 2025 , Edited by admin on Mon Mar 31 23:08:23 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY